Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : PFE (Pfizer) How high will it go? -- Ignore unavailable to you. Want to Upgrade?

To: flickerful who wrote (4693)	8/3/1998 3:22:00 PM
From: Anthony Wong	Respond to of 9523

Viagra to Be Licensed, Sold in Russia by October, UPI Says Bloomberg News August 3, 1998, 2:11 p.m. ET Moscow, Aug. 3 (Bloomberg) -- Pfizer Inc.'s anti-impotence drug Viagra has been registered for use in Russia by the Ministry of Health, and the drugmaker says the pill will be on sale there by October, making Russia the fifth country to legalize the drug, United Press International Reported. Viagra reportedly is being sold illegally on the streets of Moscow for more than $100 a dose. Health Ministry officials say the drug underwent extensive tests and only will be available by prescription, at a price of between $10-$12 a pill, UPI said. Several men have filed lawsuits against Pfizer alleging that Viagra caused them to have heart attacks. (UPI 8/3) --David Wells in the Princeton newsroom (609) 279-4053 (jjs)